. ERV1 transgenic mice are protected from diet induced obesity, hepatic steatosis and glucose intolerance. (a) Body weights of ≥6 weeks-old male FVB mice on normal control diet (NCD) or high fat diet (HFD) for 12 weeks (n = 12 NCD per group; *p = 0.0075, ANOVA repeated measures test; F (1.126, 6.755) = 13.56). (b,c) Fasting blood glucose and serum insulin were measured in WT (n = 12) and ERV1tg (n = 8) mice for 20 weeks on HFD (*p < 0.05, unpaired t-tests vs. baseline). (d) Quantitative insulin sensitivity check index (QUICKI) for mice on NCD or HFD for 16 weeks (n = 8 mice/group, *P < 0.05, t test). (e) Correlation between fasting blood glucose and body weight in mice on NCD or HFD for 16-20 weeks (*Pearson, P < 0.01, n = 12 mice/group). (f,g) Glucose (f) and insulin (g) tolerance in NCD-or HFD-fed WT and ERV1tg mice (n = 4 per group, *P < 0.05 HFD vs. NCD, t tests, Holm-Sidak correction for multiple comparisons assuming unequal variance per time point (P < 0.01), one of two similar experiments). (h) AUC for glucose (GTT) and insulin (ITT) tolerance test results for WT and ERV1tg mice (n = 4 per group, *P < 0.05 HFD vs NCD, t tests). ERV1tg mice on NCD or HFD for 18 weeks. (j,k) Representative micrographs of liver (j) and VAT (k) stained with hematoxylin and eosin, and Masson's trichrome (k, Bottom row; arrows indicate collagen). (l,n) Weights of livers (l) and single epididymal VAT (n) of WT and ERV1tg mice on NCD or HFD for 18 weeks (n = 4 mice/ group, *P < 0.05 HFD vs. NCD, t test). (m) Fat droplet size in liver of WT and ERV1tg mice on HFD for 18 weeks (n = 4 mice per group, *P < 0.05, t test). (o) Adipocyte size in VAT of mice on HFD or NCD (n = 4 per mice group, *P < 0.05 t tests). All t tests were unpaired and two tailed. Histograms represent mean ± SEM.
